We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
1651
Sysco
SYY
$40.3B
$31K ﹤0.01%
359
-8,063
-96% -$653K
TPR icon
1652
Tapestry
TPR
$32.8B
$31K ﹤0.01%
1,154
-12,724
-92% -$332K
WES icon
1653
Western Midstream Partners
WES
$19.3B
$31K ﹤0.01%
1,571
-30,949
-95% -$641K
BERY
1654
DELISTED
Berry Global Group, Inc.
BERY
$31K ﹤0.01%
709
-74
-9% -$2.93K
AVID
1655
DELISTED
Avid Technology Inc
AVID
$31K ﹤0.01%
+3,577
New +$26.3K
VRTU
1656
DELISTED
Virtusa Corporation
VRTU
$31K ﹤0.01%
682
-2,552
-79% -$104K
BITA
1657
DELISTED
Bitauto Holdings Limited
BITA
$31K ﹤0.01%
2,104
-4,558
-68% -$68.8K
AVB icon
1658
AvalonBay Communities
AVB
$26.8B
$30K ﹤0.01%
145
-3,568
-96% -$764K
EGBN icon
1659
Eagle Bancorp
EGBN
$845M
$30K ﹤0.01%
+621
New +$28.1K
MA icon
1660
Mastercard
MA
$493B
$30K ﹤0.01%
101
-9,909
-99% -$2.79M
RARE icon
1661
Ultragenyx Pharmaceutical
RARE
$2.55B
$30K ﹤0.01%
706
+672
+1,976% +$27.7K
SCHO icon
1662
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$30K ﹤0.01%
+1,200
New +$30.3K
SLF icon
1663
Sun Life Financial
SLF
$45.4B
$30K ﹤0.01%
673
-42,306
-98% -$1.9M
AD
1664
Array Digital Infrastructure
AD
$3.05B
$30K ﹤0.01%
849
-1,632
-66% -$57.2K
ZTR
1665
Virtus Total Return Fund
ZTR
$339M
$30K ﹤0.01%
+2,615
New +$29K
VOXX
1666
DELISTED
VOXX International Corporation Class A
VOXX
$30K ﹤0.01%
6,939
-2,441
-26% -$11.3K
AAP icon
1667
Advance Auto Parts
AAP
$3.49B
$29K ﹤0.01%
181
-3,781
-95% -$606K
AEO icon
1668
American Eagle Outfitters
AEO
$3.01B
$29K ﹤0.01%
2,000
-9,534
-83% -$146K
ATNI icon
1669
ATN International
ATNI
$492M
$29K ﹤0.01%
524
+129
+33% +$7.34K
AUTL
1670
Autolus Therapeutics
AUTL
$562M
$29K ﹤0.01%
+2,227
New +$29.2K
BMO icon
1671
Bank of Montreal
BMO
$127B
$29K ﹤0.01%
383
-27,849
-99% -$2.1M
BBBY
1672
Bed Bath & Beyond
BBBY
$442M
$29K ﹤0.01%
+5,449
New +$36.5K
CMA
1673
DELISTED
Comerica
CMA
$29K ﹤0.01%
405
-13,881
-97% -$953K
COKE icon
1674
Coca-Cola Consolidated
COKE
$12.8B
$29K ﹤0.01%
1,030
-420
-29% -$11.8K
CUK
1675
DELISTED
Carnival PLC
CUK
$29K ﹤0.01%
603
-2,819
-82% -$119K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.